Lokahi Therapeutics CEO provides strategic update
On Sept. 23, 2026, Glucotrack (now Lokahi Therapeutics) provided an update on its LT-100 osteoarthritis program and AI platform as a merged entity. The announcement comes closely following a July 14, 2026 business combination.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed